Navigation Links
Tufts researcher elected 2010 AAAS Fellow for work in superbugs and heat-stable vaccines
Date:1/14/2011

BOSTON (January 14, 2011) Abraham L. (Linc) Sonenshein, PhD, professor of molecular biology and microbiology at Tufts University School of Medicine and member of the genetics and molecular microbiology program faculties at the Sackler School of Graduate Biomedical Sciences at Tufts has been awarded the distinction of AAAS Fellow.

Election as a Fellow is an honor bestowed upon AAAS members by their peers. Fellows are awarded because of their scientifically or socially distinguished efforts to advance science or its applications. Sonenshein was elected for his distinguished contributions to the understanding of gene regulation, sporulation and pathogenesis in Gram-positive bacteria.

Sonenshein, who is also the acting chair of molecular biology and microbiology at Tufts School of Medicine, studies the regulation of gene transcription in the spore-forming bacteria Bacillus subtilis and Clostridium difficile, and the relationship of sporulation to pathogenesis.

His work with the "superbug," C. difficile which causes severe diarrhea in patients and sometimes death, showed that the bacteria only produce toxins when they are limited for nutrients. Essentially, protein that monitors the nutrient levels inside C. difficile cells prevents toxin production when the bacteria have enough to eat.

This and his other work with C. difficile are important steps toward the development of a drug that may prevent hospital patients from falling ill.

In ongoing work, he is collaborating with scientists at the Cummings School of Veterinary Medicine at Tufts and Boston University to use the harmless B. subtilis bacterium as the basis for low-cost, needle-free and heat-stable vaccines. In a study published in the November 2010 issue of Clinical and Vaccine Immunology, one such vaccine using nasal drops instead of needles effectively induced an immune response in mice and protected them from rotavirus infection. Rotavirus is a common cause of severe diarrheal disease that is responsible for approximately 500,000 deaths among children in the developing world every year.

The new vaccine delivery system has also been tested successfully against tetanus. A study published in Vaccine in September 2010 established that the tetanus vaccine is effective even after being stored for more than a year at 113F. The new vaccine delivery system is currently being tested with diphtheria and pertussis.


'/>"/>

Contact: Siobhan E. Gallagher
617-636-6586
Tufts University, Health Sciences
Source:Eurekalert

Related medicine news :

1. Tufts Medical Center and Boston Medical Center Nurses Hold a Joint Informational Picket to Protest Unsafe Staffing and Practice Conditions
2. Impressive lineup of speakers at Tufts nutrition conference
3. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
4. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
5. Researchers discover new way to kill pediatric brain tumors
6. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
7. Tiny fruit fly could offer big clues in fight against obesity, researcher says
8. Researchers create drug to keep tumor growth switched off
9. MSU researcher linking breast cancer patients with alternative therapies
10. UT researcher receives $2.4 million to research obesity, high-risk pregnancy
11. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced ... Foundation implement a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR ... specializes in long-term care, Brooke Grove now has the capability to achieve its ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s highly popular SearchLight Spectra ... modeling resource for fluorescence microscopists and optical system designers, enabling The Right Solution, ... spanning the globe, SearchLight has become a tremendously popular tool for the fluorescence ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Healthcare companies ... But they will rapidly reject an outdated healthcare executive resume. , “If you’re a ... at your executive resume and wondering if it’s as ready as you are for ...
(Date:4/27/2017)... Reston, VA (PRWEB) , ... April 27, 2017 ... ... mobile application containerization, today announced an exhibitor sponsorship at MobileIron Live! 2017 ... leaders, and new technologies for an immersive, educational approach to helping organizations maximize ...
(Date:4/27/2017)... ... April 27, 2017 , ... Plastic Surgery Associates is excited to announce ... present at the upcoming Aesthetic Meeting. Held in San Diego, at the San Diego ... Canales will lend their expertise to the Premier Global Hot Topics session, speaking on ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  CVS Pharmacy, the retail division ... new store design to enhance the retail customer ... health-focused products and expanded beauty selections paired with ... discover new offerings. Together with its innovative digital ... the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
Breaking Medicine Technology: